Table: Chugai Pharm -2019 group results (IFRS)

Chugai Pharmaceutical

30/01/2020 08:00

Jan 30 (Reuters)- 
              Chugai Pharmaceutical Co Ltd 
              CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified) 
                   Year ended      Year ended       Year to        NEXT  
                Dec 31, 2019    Dec 31, 2018   Dec 31, 2020      YEAR    
                   LATEST         YEAR-AGO        COMPANY      COMPANY   
                   RESULTS         RESULT        FORECAST    H1 FORECAST 
  Sales            686.18          579.79                                
                 (+18.4 pct)     (+8.5 pct)                              
  Operating        210.60          124.32                                
                 (+69.4 pct)     (+25.7 pct)                             
  Pretax
  Net              157.56           92.49                                
                 (+70.4 pct)     (+27.2 pct)                             
  EPS Basic      287.84 yen      169.08 yen                              
  EPS Diluted    287.43 yen      168.80 yen                              
  Ann Div        140.00 yen       86.00 yen                              
  -Q2 Div         48.00 yen       31.00 yen      75.00 yen               
  -Q4 Div         92.00 yen       55.00 yen      25.00 yen               
 
  NOTE - Chugai Pharmaceutical Co Ltd. 
  (Figures are reported based on international accounting rules (IFRS).) 
  If there is no Q1 or Q3 dividend, Q2 will in most cases correspond to the first-half 
  dividend and Q4 to the second-half dividend announced before a new corporate law in 
  2006 allowed companies to pay and report dividends on a quarterly basis.
  *Net - represents Net profit attributable to owners of the parent company.
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4519.T